BioRestorative Therapies (BRTX) Revenue (2012 - 2025)
BioRestorative Therapies' (BRTX) quarterly Revenue came in at $19600.0 in Q4 2025, down 54.73% on a YoY basis from $43300.0 in Q4 2024, and up 66.1% quarter-over-quarter from $11800.0 in Q3 2025.
Powered by 
Analysis
BioRestorative Therapies (BRTX) Revenue (2012 - 2025) Analysis & Trends
BioRestorative Therapies (BRTX) has reported Revenue for 14 consecutive years, with $19600.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Revenue fell 54.73% year-over-year to $19600.0; the trailing twelve-month figure through Dec 2025 stood at $359700.0 (down 10.3% YoY), and the FY2025 full-year result was $359700.0, down 10.3% from the prior year.
- Revenue climbed to $19600.0 in Q4 2025 per BRTX's latest filing, from $11800.0 in the prior quarter.
- Across five years, Revenue topped out at $303300.0 in Q2 2025 and bottomed at $3700.0 in Q4 2022.
- Historically, Revenue has averaged $53615.0 across 5 years, with a median of $27000.0 in 2022.
- The sharpest annual moves came in 2024 and 2025: Revenue soared 660.91% in 2024, then tumbled 94.95% in 2025.
- Over 5 years, Revenue stood at $5000.0 in 2021, then slipped by 26.0% to $3700.0 in 2022, then surged by 421.62% to $19300.0 in 2023, then jumped by 124.35% to $43300.0 in 2024, then sank by 54.73% to $19600.0 in 2025.
- According to Business Quant data, Revenue over the past three periods registered $19600.0, $11800.0, and $303300.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 119.22 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | 10.18 Mn |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 99.31 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 387.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | 5.84 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | 490,000.00 |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 54.98 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 401.25 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 77.46 Mn |
| 10 | BioRestorative Therapies | 62,133.68 | -2.89 Mn | 17,964.00 | 19,600.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 19,600.00 |
| Sep 30, 2025 | 11,800.00 |
| Jun 30, 2025 | 303,300.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 43,300.00 |
| Sep 30, 2024 | 233,600.00 |
| Jun 30, 2024 | 89,100.00 |
| Mar 31, 2024 | 35,000.00 |
| Dec 31, 2023 | 19,300.00 |
| Sep 30, 2023 | 30,700.00 |
| Jun 30, 2023 | 64,500.00 |
| Mar 31, 2023 | 31,300.00 |
| Dec 31, 2022 | 3,700.00 |
| Sep 30, 2022 | 29,000.00 |
| Jun 30, 2022 | 71,100.00 |
| Mar 31, 2022 | 16,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 15,000.00 |
| Mar 31, 2021 | 18,000.00 |